Alnylam Pharmaceuticals, Inc.

WORLDQUANT MILLENNIUM ADVISORS LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

343,431

Value ($000)

136,565

Weight

0.5%

2019 Q4 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	136,565	0.5%	343,431	12/31/2025
2025 Q3	11/14/2025	100,609	0.4%	220,634	9/30/2025
2025 Q2	8/14/2025	38,274	0.2%	117,373	6/30/2025
2025 Q1	5/15/2025	51,602	0.3%	191,105	3/31/2025
2024 Q4	2/14/2025	35,341	0.2%	150,191	12/31/2024
2024 Q3	11/14/2024	16,095	0.1%	58,520	9/30/2024
2024 Q2	8/14/2024	31,491	0.3%	129,593	6/30/2024
2024 Q1	5/15/2024	8,978	0.1%	60,073	3/31/2024
2023 Q4	2/14/2024	11,670	0.2%	60,967	12/31/2023
2023 Q2	8/14/2023	7,652	0.1%	40,287	6/30/2023
2023 Q1	5/15/2023	3,673	0.1%	18,338	3/31/2023
2022 Q3	11/14/2022	4,088	0.1%	20,426	9/30/2022
2021 Q2	8/16/2021	5,424	0.1%	31,999	6/30/2021
2021 Q1	5/17/2021	4,056	0.1%	28,728	3/31/2021
2020 Q4	2/16/2021	3,734	0.1%	28,728	12/31/2020
2020 Q3	11/16/2020	4,183	0.1%	28,728	9/30/2020
2020 Q2	8/14/2020	6,321	0.1%	42,679	6/30/2020
2020 Q1	5/14/2020	3,934	0.1%	36,146	3/31/2020
2019 Q4	2/14/2020	1,465	0.0%	12,722	12/31/2019